Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Ascorbic Acid in Sepsis
NCT04773717Completed
- Sponsor
- Lithuanian University of Health Sciences
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in sepsis and septic shock comparing Ascorbic acid with Placebo (2 arms). Primary endpoints: Microvascular flow index at 96 hours and Proportion of perfused small vessels at 96 hours. Started Jan 2019; status: completed.
02
Drugs
ascorbic acid
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT04773717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04773717.